REG - Assura plc - Scrip Calculation Price

AssuraAnnouncement

14/03/2024 08:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240314:nRSN8588Ga&default-theme=true

RNS Number : 8588G  Assura PLC  14 March 2024

 

14 March 2024

 

Assura plc

 

Scrip Calculation Price

Assura plc ("the Company") announces, in accordance with the terms and
conditions of the Company's Scrip Dividend Scheme ("the Scheme"), that the
Scrip Calculation Price in respect of the quarterly interim dividend
proposed to be paid on 10 April 2024, is 41.59 pence. This is the average
closing mid-market price of an ordinary share in the Company for the five
dealing days commencing with, and including, the ex-dividend date of 7 March
2024.

If you wish to receive this quarterly interim dividend in cash, you do not
need to take any action.

 

If you wish to participate in the Scheme and receive New Shares instead of
your cash dividend, you should complete a Mandate, as follows:

 

·    If you hold your Ordinary Shares in certificated form, and if you
have not already done so, you should complete the Mandate Form (which is
available to download from Assura's website www.assuraplc.com) in accordance
with the instructions printed thereon and return it to Link Group at Central
Square, 29 Wellington Street, Leeds, LS1 4DL by no later than 4.30 p.m.
(London time) on 26 March 2024. The Mandate Form will remain in force for any
future dividends in respect of which a Scrip Dividend Alternative is offered,
until such time as the Mandate Form is cancelled.

 

·    If you hold your Ordinary Shares in uncertificated form via the CREST
System, you can only elect to receive dividends in the form of New Shares by
submitting a CREST Dividend Election Input Message via the CREST System.
Evergreen elections will not be permitted. This means that if you wish to
receive New Shares instead of cash as a matter of routine whenever a Scrip
Dividend Alternative is offered, you must complete and submit a CREST Dividend
Election Input Message on each occasion, otherwise you will receive the
relevant dividend in cash.

 

If you have any questions about the Scheme or how it operates, you can contact
our Registrar, Link Group, at the address above or by telephone on 0371 664
0321. Lines are open between 9.00am and 5.30pm Monday to Friday, excluding
public holidays.

 

Based upon the above Scrip Calculation Price, if all eligible Shareholders
were to elect to take up their full entitlement to New Shares in respect of
this quarterly interim dividend, approximately 58,851,789 New Shares would be
issued. This would represent approximately 2.0 per cent. of the Company's
issued share capital as at today's date. The total cash cost of this quarterly
interim dividend if no Shareholders were to elect to take up their entitlement
(and therefore no New Shares were to be issued) would be approximately £24.5
million.

 

Words and expressions defined in the circular dated 9 December 2015 in
relation to the Scheme bear the same meanings in this announcement.

 

This interim dividend will be paid as 100% Property Income Distribution
("PID"). Forms to register for gross PIDs are available on the Company's
website. Please click here for PID Forms
(https://www.assuraplc.com/investor-relations/shareholder-information/reit-dividends-and-uk-tax)
.

 

- Ends -

 

 

 

For more information, please contact:

 Assura plc                                   Tel: 0161 515 2043
 David Purcell, Investor Relations Director   Email: Investor@assura.co.uk

 FGS Global                                   Tel: 0207 251 3801

                                            Email: Assura@fgsglobal.com
 Gordon Simpson

 

 

 Notes to Editors

Assura plc is a national healthcare premises specialist and UK REIT based in
Altrincham, UK - caring for more than 600 primary healthcare buildings, from
which over six million patients are served.

 

A constituent of the FTSE 250 and the EPRA* indices, as at 30 September 2023,
Assura's portfolio was valued at £2.7 billion.

 

At Assura, we BUILD for health. Assura builds better spaces for people and
places, invests in skills and inspires new ways of working, and unlocks the
power of design and innovation to deliver lasting impact for communities -
aiming for six million people to have benefitted from improvements to and
through its healthcare buildings by 2026.

 

Assura is leading for a sustainable future, targeting net zero carbon across
its portfolio by 2040.

 

Further information is available at www.assuraplc.com
(http://www.assuraplc.com)

 

*EPRA is a registered trademark of the European Public Real Estate
Association.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVSFISALELSEED